Hyperactivation of RAS/RAF/MEK/ERK signaling by germline mutations induces developmental disorders termed as RASopathies[4,5], whereas that by somatic alterations causes human cancers[6,7]. This evidence concerns the gene MAPK1 and RASopathy.